Search for an orphan drug
Other search option(s)
REVLIMID
LenalidomideMarketing authorisation without orphan designation - Europe
- Diseases list
- Multiple myeloma
- Follicular lymphoma
- Mantle cell lymphoma
- Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
- Detailed information
Marketing authorisation with orphan designation - USA
- Diseases list
- MALT lymphoma
- Multiple myeloma
- Follicular lymphoma
- Mantle cell lymphoma
- Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality
- Detailed information
Marketing authorisation with orphan designation - Australia
- Diseases list
- Multiple myeloma
- Myelodysplastic syndrome
- Detailed information
Additional information
Research on this medical product
Appraisal/reimbursement
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.